Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FURIN | P09958 | 2/20 | 0.52 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.51 |
| ▸ | BCL2A1 | Q16548 | 4/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 11/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8550341 | 0.77 | FURIN (0.44) | FURINPARP10FFAR4 | |
| SCHEMBL8546442 | 0.76 | ALOX5 (0.51) | PARP10ALOX5 | |
| SCHEMBL8545668 | 0.75 | PARP10 (0.59) | PARP10ALOX5 | |
| SCHEMBL16902888 | 0.75 | FURIN (0.56) | FURINPARP10FFAR4 | |
| SCHEMBL8550223 | 0.74 | ALOX5 (0.56) | ALOX5 | |
| SCHEMBL8550197 | 0.72 | MMP2 (0.49) | ALOX5 | |
| SCHEMBL8546020 | 0.72 | FURIN (0.51) | FURINPARP10FFAR4 | |
| SCHEMBL8546769 | 0.71 | ITGB3 (0.49) | ALOX5 | |
| SCHEMBL8545311 | 0.71 | ITGB3 (0.49) | ALOX5 | |
| SCHEMBL8549962 | 0.71 | ITGB3 (0.49) | ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0696585-B1 | NOVEL BISOXADIAZOLIDINE DERIVATIVE | YAMANOUCHI PHARMA CO LTD (JP) | 1998-12-16 | — | — | EP | disclosed |
| US-5643931-A | ANTIDIABETIC AGENTS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1997-07-01 | — | — | US | disclosed |
| EP-0696585-A1 | NOVEL BISOXADIAZOLIDINE DERIVATIVE | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1996-02-14 | — | — | EP | disclosed |